Insulin Resistance IGT Diabetes Metformin

Studies in Impaired Glucose toleance

 

 

DPP

Finnish DPS

STOP NIDDM

DA QING

SLIM

Table showing summary of above studies

Tolbutamide- a short acting sulphonylureas has been shown to reduce the conversion of IGT to T2DM although study designs were less than modern.

•

 

 

 

 

 

DPP (diabetes prevention programme)

•

USA 2002

•3234 subjects

•>25 years age     Mean age 51 years

•Mean BMI  34

•FBS  5.3-6.9       2hr 7.8-11  i.e. IGT

•Placebo or Metformin 850 BD

•+ lifestyle advice

The goals were to:

  • achieve and maintain a weight loss of 7 percent with healthy eating and increased physical activity

  • maintain physical activity at least 150 minutes a week with moderate exercise, such as walking or biking.

•2.8 years follow up

 

•Outcome:

    Reduction of risk of diabetes

        Life style- 58%

        Metformin- 31%

Clearly lifestyle interventions were better than metformin itself!!

 

•

--------------------------------------------------------------------------------------------------

 

 

 

F-DPS (Finish Diabetes prevention study)

Finnish

•Open randomised prospective
•522  Middle-aged; overweight; IGT
•Lifestyle vs. control
•1985 WHO diabetes criteria
•Follow up for 3.2 years
•

Outcome:

  Diabetes incidence

Control group 23%
Intervention (Lifestyle) group 11%
Relative risk reduction of 58%

 

•

Read further on DPS

ref: Br J Nutr. 2000 Mar;83 Suppl 1:S137-42.

 

•

--------------------------------------------------------------------------------------------------

 

 

 

 

 

 

STOP-NIDDM

 

•International multicenter

•1368 subjects

•40-70 years age

•BMI 25-40

•IGT with FBS 5.6-7.8

•Acarbose 100 mg tds vs. placebo

•3.3 years; intention to treat analysis

•Outcome: Diabetes incidence:

Acarbose group 32.4%

Placebo 41.5%

relative risk reduction of 25%

Read further on STOP- NIDDM (PDF)

 

 

--------------------------------------------------------------------------------------------------

 

 

 

 

Da Qing Study:

•China 1997

•577 subjects

•>25 years age

•Mean BMI 25

•IGT

•Diet, exercise, diet &exercise, general advice

•6 year follow up

•Diabetes Incidence in the respective groups:

    44%, 41%, 46%, 68%.

 

The Da Qing IGT and Diabetes Study. Pan X-R 1 , Li G-W, Hu Y-H et al. Diabetes Care 1997; 20/4: 537 44.

 

 

--------------------------------------------------------------------------------------------------

 

 

SLIM study

Ongoing study from netherlands

A total of 102 subjects with IGT  randomised into two groups.
Subjects in the intervention group received regular dietary advice, and were stimulated to lose weight and to increase their physical activity. The control group received only brief information about the beneficial effects of a healthy diet and increased physical activity. Before and after the first year, glucose tolerance was measured and several other measurements were done.

RESULTS:

Body weight loss after 1 y was higher in the intervention group.
 

The 2-h blood glucose concentration decreased 0.8+/-0.3 mmol/l in the intervention group and increased 0.2+/-0.3 mmol/l in the control group     (P<0.05). Body weight loss and increased physical fitness were the most important determinants of improved glucose tolerance and insulin sensitivity.

 

Full text: Int J Obes Relat Metab Disord. 2003 Mar;27(3):377-84.

 

 

 

Summary Table of diabetes prevention studies

Study Country Duration Criteria Age,      Mean BMI Intervention Incidence of DMLifestyle  vs placebo RRR NNT
Da Qing China 6 yrs IGT ,577    45 yrs,    BMI 25.8 Diet, Exercise or both    66 vs 44        46   4.5
DPS Finland 4 yrs IGT, 522    55 yrs,     BMI 31 Diet, Exercise    23  vs 11        58    8
DPP USA 3 yrs IGT, 3234   51 yrs    BMI 31 lifestyle or Metformin   28   vs  14        58   7
                        Metformin vs placebo                                                                28  vs  21      31           14

STOP NIDDM

Canada, Germany, Austria, Israel, Spain

3 yrs

IGT,   1429

55 yrs    BMI 31

Acarbose

  42  vs  32

        24

  11

 

 

 

 

 

 

 
References:

 

Br J Nutr. 2000 Mar;83 Suppl 1:S137-42.

 

The Finnish Diabetes Prevention Study.

Uusitupa M, Louheranta A, Lindstrom J, Valle T, Sundvall J, Eriksson J, Tuomilehto J.

The aim of the Finnish Diabetes Prevention Study is to assess the efficacy of an intensive diet-exercise programme in preventing or delaying type 2 diabetes in individuals with impaired glucose tolerance (IGT) and to evaluate the effect of the programme on the risk factors of atherosclerotic vascular diseases and the incidence of cardiovascular events. In this ongoing study, a total of 523 overweight subjects with IGT based on two oral glucose tolerance tests were randomized to either an intervention group or a control group. The main measure in the intervention group is individual dietary advice aimed at reducing weight and intake of saturated fat and increasing intake of dietary fibre. The intervention subjects are individually guided to increase their level of physical activity. The control group receives general information about the benefits of weight reduction, physical activity and healthy diet in the prevention of diabetes. A pilot study began in 1993, and recruitment ended in 1998. By the end of April 1999 there were 65 new cases of diabetes, 34 drop-outs and one death. The weight reduction was greater (-4.6 kg) at 1 year in the intervention group (n = 152) than in the control group (n = 143, -0.9 kg, P < 0.0001), and this difference was sustained in the second year of follow-up. At 1 year 43.4% and at 2 years 41.8% of the intervention subjects had achieved a weight reduction of at least 5 kg, while the corresponding figures for the control subjects were 14.0 and 12.0% (P < 0.001 between the groups). At 1 year the intervention group showed significantly greater reductions in 2 h glucose, fasting and 2 h insulin, systolic and diastolic blood pressure, and serum triglycerides. Most of the beneficial changes in cardiovascular risk factors were sustained for 2 years. These interim results of the ongoing Finnish Diabetes Prevention Study demonstrate the efficacy and feasibility of the lifestyle intervention programme.

 

 

 

Int J Obes Relat Metab Disord. 2003 Mar;27(3):377-84.  


Study on Lifestyle Intervention and Impaired Glucose Tolerance Maastricht (SLIM): preliminary results after one year.   

Mensink M, Feskens EJ, Saris WH, De Bruin TW, Blaak EE.


AIMS: Important risk factors for the progression from impaired glucose tolerance to type II diabetes mellitus are obesity, diet and physical inactivity. The aim of this study is to evaluate the effect of a lifestyle-intervention programme on glucose tolerance in Dutch subjects with impaired glucose tolerance (IGT). METHODS: A total of 102 subjects were studied, randomised into two groups. Subjects in the intervention group received regular dietary advice, and were stimulated to lose weight and to increase their physical activity. The control group received only brief information about the beneficial effects of a healthy diet and increased physical activity. Before and after the first year, glucose tolerance was measured and several other measurements were done. RESULTS: Body weight loss after 1 y was higher in the intervention group. The 2-h blood glucose concentration decreased 0.8+/-0.3 mmol/l in the intervention group and increased 0.2+/-0.3 mmol/l in the control group (P<0.05). Body weight loss and increased physical fitness were the most important determinants of improved glucose tolerance and insulin sensitivity. CONCLUSION: A lifestyle-intervention programme according to general recommendations is effective and induces beneficial changes in lifestyle, which improve glucose tolerance in subjects with IGT. Body weight loss and increased physical fitness were the most important determinants of improved glucose tolerance and insulin sensitivity

          Read more about studies in diabetes prevention here  (needs free registration at the site)

          Read more about IGT at the International Diabetes Federation website

 

Insulin Resistance IGT Diabetes Metformin

 

 

This page was last updated on : 16/01/2007